These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19575008)

  • 1. The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells.
    He Y; Yuan XM; Lei P; Wu S; Xing W; Lan XL; Zhu HF; Huang T; Wang GB; An R; Zhang YX; Shen GX
    Acta Pharmacol Sin; 2009 Jul; 30(7):1053-9. PubMed ID: 19575008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human somatostatin receptor-3 distinctively induces apoptosis in MCF-7 and cell cycle arrest in MDA-MB-231 breast cancer cells.
    War SA; Kim B; Kumar U
    Mol Cell Endocrinol; 2015 Sep; 413():129-44. PubMed ID: 26112183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways.
    Zou Y; Xiao X; Li Y; Zhou T
    Oncol Rep; 2009 Feb; 21(2):379-86. PubMed ID: 19148511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity.
    Taylor JE; Theveniau MA; Bashirzadeh R; Reisine T; Eden PA
    Peptides; 1994; 15(7):1229-36. PubMed ID: 7854974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors.
    Zheng N; Dai W; Du W; Zhang H; Lei L; Zhang H; Wang X; Wang J; Zhang X; Gao J; Zhang Q
    Mol Pharm; 2012 May; 9(5):1175-88. PubMed ID: 22435704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer.
    Frati A; Rouzier R; Lesieur B; Werkoff G; Antoine M; Rodenas A; Darai E; Chereau E
    Anticancer Res; 2014 Aug; 34(8):3997-4003. PubMed ID: 25075022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line.
    Leu FP; Nandi M
    Pancreas; 2010 Nov; 39(8):1155-66. PubMed ID: 20531241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive and follicle-stimulating hormone-induced action of somatostatin receptor-2 on regulation of apoptosis and steroidogenesis in bovine granulosa cells.
    Riaz H; Dong P; Shahzad M; Yang L
    J Steroid Biochem Mol Biol; 2014 May; 141():150-9. PubMed ID: 24530462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell death of MCF-7 human breast cancer cells induced by EGFR activation in the absence of other growth factors.
    Garcia R; Franklin RA; McCubrey JA
    Cell Cycle; 2006 Aug; 5(16):1840-6. PubMed ID: 16861904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.
    Kouch-el Filali M; Kilic E; Melis M; de Klein A; de Jong M; Luyten GP
    Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1585-92. PubMed ID: 18682975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse.
    Hennigs JK; Müller J; Adam M; Spin JM; Riedel E; Graefen M; Bokemeyer C; Sauter G; Huland H; Schlomm T; Minner S
    PLoS One; 2014; 9(7):e100469. PubMed ID: 25010045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor ligands and resistance to treatment in pituitary adenomas.
    Cuevas-Ramos D; Fleseriu M
    J Mol Endocrinol; 2014 Jun; 52(3):R223-40. PubMed ID: 24647046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
    Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T
    J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
    Xu Y; Song J; Berelowitz M; Bruno JF
    Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
    Watt HL; Kharmate GD; Kumar U
    Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.